Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability
A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the bending stiffness of scoliotic spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the scoliotic curve. Alternatively, contact between the tissue and the crosslinking reagent is affected by placement of a time-release delivery system directly into or onto the target tissue. Methods and devices that use crosslinking agents for increasing the permeability of an intervertebral disc, improving fluid flux to the intervertebral disc, and increasing the biological viability of cells within the intervertebral disc are provided.
1. A method of improving the stabilization of intervertebral discs by reducing the bending hysteresis of scoliotic spines comprising the step of:
contacting at least a portion of a collagenous tissue within the discs with an effective amount of a crosslinking reagent.
2. A method of improving the stabilization of intervertebral discs by increasing the bending stiffness of scoliotic spines comprising the step of:
contacting at least a portion of a collagenous tissue within the discs with an effective amount of a crosslinking reagent.
3. The method of claims 1 or 2 , wherein the crosslinking reagent is injected into the convex side of discs involved in the scoliotic spine.
4. The method of claims 1 or 2 , further comprising performing corrective surgery to stabilize the discs.
5. The method of claims 1 or 2 , further comprising wearing an external brace to stabilize the discs.
6. The method of claims 1 or 2 , wherein the crosslinking reagent is selected from the group consisting of genipin, proanthocyanidin, ribose, threose, and lysyl oxidase.
7. The method of claims 1 or 2 , further comprising contacting at least a portion of a collagenous tissue within the tissues adjacent to the discs with an effective amount of a crosslinking reagent.
8. The method of claims 1 or 2 , wherein the contact between the collagenous tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the portion of the collagenous tissue.
9. The method of claims 1 or 2 , further comprising using three-dimensional reconstructions of the collagenous tissue to determine where to contact the collagenous tissue with the crosslinking reagent.